Next Vial names its dispensing pharmacy with a street address and telephone number, and enumerates the forty-nine states it serves rather than printing a count. Against that, four of its five peptide products show a plan selector where a price should be, so only one figure on the site is actually visible.
What Next Vial charges
Glutathione: $149.99 — starting at, the bottom of a range; the page names no billing period
Next Vial also sells 3 compounds this site boards without publishing a price for them: Sermorelin, NAD+ and PT-141.
Next Vial is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A named pharmacy and a real state list
It names Manifest Pharmacy with a street address in Greer, South Carolina and a telephone number, and it names the clinician network that reviews the intake.
Its state coverage is enumerated rather than counted: forty-nine states are listed by name, with Alaska absent.
A list can be checked, which is why it is recorded here. Forty-nine is also not fifty, so no nationwide claim is credited.
One price visible out of five products
Its glutathione page prints a starting-at figure. Its sermorelin, PT-141, injectable NAD+ and nasal NAD+ pages are structurally identical to it and print "Select plan" in the place where that figure sits.
Visible text is the test, so only the glutathione figure is filed and the other four products are recorded as unpriced.
The one figure that is visible carries no billing period either, so it is recorded as not monthly.
The headline weight-loss figure covers two drugs
A headline advertises doctor-led weight-loss plans as low as a stated monthly floor.
The control directly beneath it offers both semaglutide and tirzepatide.
One floor across two compounds is not a price for either, so nothing is filed from it.
What it says about legal category
In its own words: "Please note that compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy."
It continues: "However, they are prepared by licensed compounding pharmacies in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act."
It also says plainly that it does not manufacture compounded medications, and it publishes no certificate of analysis.
Who it's for
Readers who want the dispensing pharmacy named with an address they can check.
Buyers who want an enumerated state list rather than a count.
Shoppers who want to know which clinician network reviews the intake.
Anyone buying glutathione, which is the one product with a visible figure.
Who should look elsewhere
Readers who want a price before starting a plan selector.
Buyers of sermorelin, PT-141 or NAD+, none of which show a figure.
Anyone in Alaska, which is absent from its own list.
Shoppers who need a per-drug weight-loss price rather than a shared floor.
Strengths
Names its dispensing pharmacy with a street address and a telephone number
Lists the forty-nine states it serves rather than printing a count
Names the clinician network that reviews the intake
States plainly that compounded medicines are not FDA-reviewed
Trade-offs
Four of its five peptide products show a plan selector where a price should be
Its weight-loss floor covers two different drugs behind one figure
The one published figure names no billing period
Alaska is absent from its own state list, so the coverage is not nationwide
How we verified this
Opened all five peptide product pages and confirmed four print a plan selector in the position where the glutathione page prints a figure, then filed only the visible one.
Read the state list item by item and confirmed it enumerates forty-nine states with Alaska absent, so it is a list rather than a count.
Read the weight-loss headline together with the control beneath it, confirmed the floor spans two compounds, and filed nothing from it.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand and its named pharmacy against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, with a positive and a nonsense control in the same run. No letters for either.
A provider to compare Next Vial against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Four of its five peptide pages render a plan selector where the glutathione page renders a figure. Nothing is recorded for those four, because visible text is the test.
Is the glutathione price monthly?
No. It is a starting-at figure at the bottom of a range, and the page names no billing period.
Does it ship to my state?
It lists forty-nine states by name. Alaska is the one absent from that list, so coverage is broad but not nationwide.
Who dispenses the medication?
It names Manifest Pharmacy, with a street address in Greer, South Carolina and a telephone number, and says it does not manufacture compounded medications itself.
Next Vial is not a paid partner; this link may earn a commission if that changes. Full disclosure.